Matthew A. Menza
Matthew A. Menza publishes mostly in Neurology, Psychiatry and Mental health and Cognitive Neuroscience, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Treatment of Major Depression.
- World rank
- #498,858 of 7,710,434 ranked researchers
- Rank in United States
- #173,927 of 1,627,098
- Works
- 96
- Citations
- 6.4k
- Citations per work
- 66.2
What does Matthew A. Menza research?
Matthew A. Menza's work is mostly in Medicine (49%), Neuroscience (14%), Psychology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4748.8%
- Medicine4748.8%
- Everything else3031.6%
- Life Sciences1313.7%
- Neuroscience1313.7%
- Social Sciences65.9%
- Psychology65.9%
- 1Neurology28% of their works
- 2Psychiatry and Mental health15% of their works
- 3Cognitive Neuroscience7% of their works
- 4Cellular and Molecular Neuroscience6% of their works
- 5Clinical Psychology6% of their works
- 6Pharmacology6% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Treatment of Major Depression
- Autism Spectrum Disorder Research
- Neurotransmitter Receptor Influence on Behavior
- Schizophrenia research and treatment
- Attention Deficit Hyperactivity Disorder
- Sexual function and dysfunction studies
Which keywords describe Matthew A. Menza's research?
The keywords of their largest research topics: Parkinson's Disease, a-Synuclein, Neurodegeneration, Treatment-Resistant Depression, Deep Brain Stimulation, Subthalamic Nucleus, Genetics and Antidepressant.
- Erectile Dysfunction
- ADHD
- Antipsychotic Drugs
- Dopamine
- Autism Spectrum Disorders
- Antidepressant
- Subthalamic Nucleus
- Treatment-Resistant Depression
- Neurodegeneration
- Parkinson's Disease
- a-Synuclein
- Deep Brain Stimulation
- Genetics
- Depression
- Neurodevelopmental Disorders
- Serotonin
- Neurocognitive Deficits
- Attention-Deficit/Hyperactivity Disorder
- Sexual Dysfunction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Parkinson's Disease672 topics
- Neurodegeneration421 topic
- a-Synuclein421 topic
- Treatment-Resistant Depression372 topics
- Deep Brain Stimulation251 topic
- Subthalamic Nucleus251 topic
- Genetics182 topics
- Antidepressant121 topic
- Depression121 topic
- Autism Spectrum Disorders111 topic
- Neurodevelopmental Disorders111 topic
- Dopamine91 topic
- Serotonin91 topic
- Antipsychotic Drugs81 topic
- Neurocognitive Deficits81 topic
- ADHD71 topic
- Attention-Deficit/Hyperactivity Disorder71 topic
- Erectile Dysfunction61 topic
- Sexual Dysfunction61 topic
Where does Matthew A. Menza work?
Matthew A. Menza's main affiliation in the publication record is Johnson University, United States.
How many publications and citations does Matthew A. Menza have?
OpenAlex counts 96 works and 6,353 citations for Matthew A. Menza, an h-index of 39, ranking #498,858 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matthew A. Menza. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.